
Genetics and gene therapy
When we talk about gene therapy we are usually referring to use of a harmless virus, called a vector, to deliver a normal copy of a defective gene into the cells of the eye.
Search results
When we talk about gene therapy we are usually referring to use of a harmless virus, called a vector, to deliver a normal copy of a defective gene into the cells of the eye.
These frequently asked questions should provide a response for most of the queries you might raise.
Retina UK aims not only to progress research along established threads, but to stimulate new thinking, encourage innovative approaches and nurture original ideas.
These are some of the most commonly asked questions about volunteering for our charity.
Dr Daniel Jackson discusses what images you are likely to have during a hospital appointment; how they are taken; why we take them; how we interpret them; and how this helps in the management and treatment of retinal conditions
VisionAid is a family owned and run business who have been providing solutions to visually impaired people since 1996 and are now one of the largest specialist low vision and blindness product suppliers in the UK.
Jing Yu is a Research Assistant at the Nuffield Department of Clinical Neurosciences at the John Radcliffe Hospital in Oxford.
As people living with sight loss we are constantly looking for solutions to make our lives easier without too much effort or cost writes Jonathan Abro.
Last year, with your help, we raised an incredible £53,752, which made great strides in helping our medical research recover from the pandemic.